The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.

Eumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis. It is characterized by the formation of multiple discharging sinuses. It is usually treated by antifungal agents but it is assumed that the therapeutic eff...

Full description

Bibliographic Details
Main Authors: Najwa A Mhmoud, Ahmed Hassan Fahal, El Sheikh Mahgoub, Wendy W J van de Sande
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-06-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4063734?pdf=render
_version_ 1818939196996321280
author Najwa A Mhmoud
Ahmed Hassan Fahal
El Sheikh Mahgoub
Wendy W J van de Sande
author_facet Najwa A Mhmoud
Ahmed Hassan Fahal
El Sheikh Mahgoub
Wendy W J van de Sande
author_sort Najwa A Mhmoud
collection DOAJ
description Eumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis. It is characterized by the formation of multiple discharging sinuses. It is usually treated by antifungal agents but it is assumed that the therapeutic efficiency of these agents is reduced by the co-existence of Staphylococcus aureus co-infection developing in these sinuses. This prospective study was conducted to investigate the safety, efficacy and clinical outcome of combined antibiotic and antifungal therapy in eumycetoma patients with superimposed Staphylococcus aureus infection. The study enrolled 337 patients with confirmed M. mycetomatis eumycetoma and S. aureus co-infection. Patients were allocated into three groups; 142 patients received amoxicillin-clavulanic acid and ketoconazole, 93 patients received ciprofloxacin and ketoconazole and 102 patients received ketoconazole only. The study showed that, patients who received amoxicillin-clavulanic acid and ketoconazole treatment had an overall better clinical outcome compared to those who had combined ciprofloxacin and ketoconazole or to those who received ketoconazole only. In this study, 60.6% of the combined amoxicillin-clavulanic acid/ketoconazole group showed complete or partial clinical response to treatment compared to 30.1% in the ciprofloxacin/ketoconazole group and 36.3% in the ketoconazole only group. The study also showed that 64.5% of the patients in the ciprofloxacin/ketoconazole group and 59.8% in the ketoconazole only group had progressive disease and poor outcome. This study showed that the combination of amoxicillin-clavulanic acid and ketoconazole treatment is safe and offers good clinical outcome and it is therefore recommended to treat eumycetoma patients with Staphylococcus aureus co-infection.
first_indexed 2024-12-20T06:19:55Z
format Article
id doaj.art-13ed5689cfb54affb90d859b78abecf5
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-20T06:19:55Z
publishDate 2014-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-13ed5689cfb54affb90d859b78abecf52022-12-21T19:50:25ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-06-0186e295910.1371/journal.pntd.0002959The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.Najwa A MhmoudAhmed Hassan FahalEl Sheikh MahgoubWendy W J van de SandeEumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis. It is characterized by the formation of multiple discharging sinuses. It is usually treated by antifungal agents but it is assumed that the therapeutic efficiency of these agents is reduced by the co-existence of Staphylococcus aureus co-infection developing in these sinuses. This prospective study was conducted to investigate the safety, efficacy and clinical outcome of combined antibiotic and antifungal therapy in eumycetoma patients with superimposed Staphylococcus aureus infection. The study enrolled 337 patients with confirmed M. mycetomatis eumycetoma and S. aureus co-infection. Patients were allocated into three groups; 142 patients received amoxicillin-clavulanic acid and ketoconazole, 93 patients received ciprofloxacin and ketoconazole and 102 patients received ketoconazole only. The study showed that, patients who received amoxicillin-clavulanic acid and ketoconazole treatment had an overall better clinical outcome compared to those who had combined ciprofloxacin and ketoconazole or to those who received ketoconazole only. In this study, 60.6% of the combined amoxicillin-clavulanic acid/ketoconazole group showed complete or partial clinical response to treatment compared to 30.1% in the ciprofloxacin/ketoconazole group and 36.3% in the ketoconazole only group. The study also showed that 64.5% of the patients in the ciprofloxacin/ketoconazole group and 59.8% in the ketoconazole only group had progressive disease and poor outcome. This study showed that the combination of amoxicillin-clavulanic acid and ketoconazole treatment is safe and offers good clinical outcome and it is therefore recommended to treat eumycetoma patients with Staphylococcus aureus co-infection.http://europepmc.org/articles/PMC4063734?pdf=render
spellingShingle Najwa A Mhmoud
Ahmed Hassan Fahal
El Sheikh Mahgoub
Wendy W J van de Sande
The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
PLoS Neglected Tropical Diseases
title The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
title_full The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
title_fullStr The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
title_full_unstemmed The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
title_short The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
title_sort combination of amoxicillin clavulanic acid and ketoconazole in the treatment of madurella mycetomatis eumycetoma and staphylococcus aureus co infection
url http://europepmc.org/articles/PMC4063734?pdf=render
work_keys_str_mv AT najwaamhmoud thecombinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection
AT ahmedhassanfahal thecombinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection
AT elsheikhmahgoub thecombinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection
AT wendywjvandesande thecombinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection
AT najwaamhmoud combinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection
AT ahmedhassanfahal combinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection
AT elsheikhmahgoub combinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection
AT wendywjvandesande combinationofamoxicillinclavulanicacidandketoconazoleinthetreatmentofmadurellamycetomatiseumycetomaandstaphylococcusaureuscoinfection